NAFDAC alerts public on sale of counterfeit TANDAK injection in Nigeria 

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public warning regarding the sale of counterfeit TANDAK injection 1.5g powder and water for injection, manufactured by Intracin Pharmaceuticals PVT. LTD in Gujarat, India.  

The discovery of this product in Gombe state, Nigeria, was reported to the agency by Marcson Healthcare Ltd., the Marketing Authorization Holder (MAH). 

TANDAK® injection of 1.5g powder is a crucial co-formulation of Ceftriaxone 1000mg and Sulbactam 500mg, prescribed for treating various bacterial infections. Its efficacy relies on the supervision of healthcare professionals, ensuring proper administration and monitoring.